HAVEL & PARTNERS | Czech Republic

»»»«««

»»»«««

Mergers & Acquisitions and Life Sciences, Pharmaceutical and Healthcare Law are among key areas of HAVEL & PARTNERS’ practice.

»»»«««

HAVEL & PARTNERS, with offices in Prague, Brno, Ostrava, Olomouc, Pilsen (Czech Republic) and Bratislava (Slovakia), has a team of more than 320 lawyers, tax advisors and patent attorneys, approx. 200 associates and 500 employees in total, and is the largest independent law firm in Central Europe.

»»»«««

Mergers & Acquisitions

HAVEL & PARTNERS is a CEE leader in M&A, including mainly mergers, acquisitions, divestitures and reorganizations of business enterprises and companies. Our highly experienced and strongly specialized M&A team comprises of almost 80 lawyers, which makes us, according to available information, the largest and most specialized team in the Czech Republic and in Slovakia. Our lawyers have participated in the most complex M&A transactions, transformations and restructuring projects carried out on the Czech and Slovak markets, particularly by foreign investors, including transactions with significant Life Sciences components.

»»»«««

Life Sciences, Pharmaceutical and Healthcare Law

We have been focusing on the business and legal regulation of the pharmaceutical and health sectors (Life Sciences) for a long time now. Thanks to our specialised team comprising approx. 15 lawyers, including three partners, we are equipped with unique know-how, practical experience and detailed knowledge of market standards.

Our clients are leading global manufacturers of pharmaceuticals, medical devices, addictive substances, cosmetic products and food supplements, distributors, hospitals, clinics, private physicians, research institutes, laboratories, pharmacies, biotechnological companies, and other entities doing business in these fields or exercising state authority.

We advise our clients in individual pharmaceutical and health sector regulation areas and in other specialised areas closely related to them, particularly the area of personal data protection, public procurement, competition and IP/IT. When advising in these particular specialised areas, we draw on our extensive practical experience. Our services take into account all specifics of the pharmaceutical and health sectors.

Our team has also an extensive experience in building, managing and auditing compliance programmes in pharmaceutical / healthcare sectors.

»»»«««

Major transactions in the Pharmaceutical sector

• Centene: advising on the divestment of the Ribera Salud Grupo to Vialto Partners
• Fresenius: advising on the contemplated acquisition of local specialist ambulance center in Brno
• Fresenius: advising on the acquisition of INNEF, a.s.
• Ribera Salud Grupo: advising on acquisition of the Slovak ProDiagnostic Group
• Ribera Salud Grupo: advising on acquisition of the Czech PROGRESS MEDICAL
• Esthé (Czech premium plastic surgery clinic): advising the major shareholder on rearrangement of the shareholder structure
• Immunoflow (Czech alergo/imuno laboratories): advising the selling shareholders on contemplated restructuring and divestment of the company

Major projects in Pharmaceutical and Healthcare law

• A long-term daily advisory to a global Swiss medicinal products and medical devices manufacturer on interactions with healthcare professionals and healthcare organizations, advisory concerning distribution models, commercial arrangements with pharmacies and hospitals, including pricing and rebate schemes, reimbursement of pharmaceuticals, regulation of advertisement of pharmaceuticals, competition law aspects of intended business practices and unfair competition.
• Advising a global U.S. medicinal products and medical devices manufacturer, on the distribution model of medical devices intended for patient use in the Czech Republic and Slovakia.
• A long-term daily advisory to a global U.S. medicinal products manufacturer in complex compliance matters (setting up, monitoring and auditing a robust compliance system, including training of employees, transparency reports etc.) for the Czech and Slovak markets.
• Advising a global U.S. medicinal products manufacturer on the Czech and Slovak launch of a highly innovative medicinal product bearing an orphan indication (gene therapy), including pre-registration distribution, pricing and reimbursement and setting up specific quality arrangements with administering centres.
• Advising an EU telemedicinal start-up on a legal framework for distant healthcare provision to Czech patients, including setting up a proper business strategy, data protection matters, IT and cybersecurity regulations.
• Advising an EU medicinal products manufacturer on all complex legal matters regarding clinical trials in the Czech Republic.

HAVEL & PARTNERS, Florentinum, Na Florenci 15, Prague 1, Czech Republic

tel: +420 255 000 111
web: https://www.havelpartners.com/
Biolegis contact:
Kateřina Slavíková
e-mail:
vaclav.audes@havelpartners.cz

Our specialist Kateřina Slavíková is happy to meet you.

Make appointment

More info

Our specialist Denisa Fuchsová is happy to meet you.

Make appointment

More info